ICH Consults On Harmonized Standards For Choosing Estimands In Clinical Trials
Executive Summary
An addendum to the International Council for Harmonisation's guideline on statistical principles for clinical trials proposes a new framework on how the concept of estimands can be used to help clearly describe the effects of a medicine.
You may also be interested in...
EMA Seeks To Update & Improve Guidance On Non-Inferiority Trials
The European Medicines Agency expects its new guideline will improve planning of confirmatory trials that include non-inferiority and therapeutic equivalence comparisons.
Clear Rules Needed For Disclosing Clinical Trial Estimands
Although estimands are a great tool for clarifying the treatment effects that are being investigated in a clinical trial, existing registries are not well suited for their public disclosure. Industry-wide guidance can help sponsors using different approaches.
Differences Put Aside As ICH Finalizes Guide On Post Approval Changes
An international guideline on managing post approval changes to drugs, which was initially criticized because of its incompatibility with legal frameworks in certain ICH regions such as the EU, has been finalized.